Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.

ABSTRACT:

Introduction

Methadone and buprenorphine are effective treatment for opioid use disorder (OUD), yet they are vastly under-utilized across US hospitals. To inform a national trial assessing the effectiveness of implementation strategies to increase adoption of an inpatient hospital-based opioid treatment (HBOT) model (NCT04921787), we explored barriers and facilitators to expanding medication for opioid use disorder (MOUD) within community hospitals across the United States.

Methods

From November 2021 to March 2022, we used purposeful and snowball sampling to identify and interview participants involved in inpatient care of patients with OUD from twelve community hospitals. We conducted semi-structured interviews on providers' experiences and perspectives on current treatment

SUBMITTER: Shearer R 

PROVIDER: S-EPMC11749276 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature